Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation

Clinical trial NCT05417971 · RECRUITING

Trial details

NCT number: NCT05417971
Sponsor: Northside Hospital, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Hematologic Malignancy

Start date: 2022-08-29
Primary completion: 2026-07-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.